MedPath
HSA Approval

METRONIDAZOLE INTRAVENOUS INFUSION 500 mg/100 ml

SIN01260P

METRONIDAZOLE INTRAVENOUS INFUSION 500 mg/100 ml

METRONIDAZOLE INTRAVENOUS INFUSION 500 mg/100 ml

May 14, 1988

B. BRAUN SINGAPORE PTE LTD

B. BRAUN SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantB. BRAUN SINGAPORE PTE LTD
Licence HolderB. BRAUN SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

J01XD01

metronidazole

Manufacturer Information

B. Braun Singapore Pte Ltd.

B BRAUN MEDICAL INDUSTRIES SDN BHD

Active Ingredients

METRONIDAZOLE

5.000g/1000ml

Metronidazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

METRONIDAZOLE INTRAVENOUS INFUSION 500 mg/100 ml - HSA Approval | MedPath